Skip to main content
. Author manuscript; available in PMC: 2015 Nov 10.
Published in final edited form as: Int J Cancer. 2015 May 6;137(7):1587–1597. doi: 10.1002/ijc.29535

Figure 1.

Figure 1

SLC1A5 expression predicts response to GPNA in NSCLC. (a) WB analysis of SLC1A5 expression in a panel of non-small cell lung cancer (NSCLC) and human bronchial airway epithelial (HBE) cell lines. A semiquantitative densitometric measurement of the SLC1A5 band intensity normalized to corresponding β-actin using ImageJ software was shown. (b) Sensitivity profile in response to GPNA treatment at 500 μM after 6 days of culture expressed as (% growth/control). All data are the averages ±SD of at least three separate determinations. (c) Spearman correlation showing sensitivity to 500 μM GPNA treatment expressed as relative growth rates shown as % growth normalized to the DMSO-treated cells (control), and protein expression level of SLC1A5 expressed as relative densitometry.